CAS: 7729-30-8; (R)-Azetidine-2-Carboxylic Acid

该化合物是一种环状氨酸,其特点是四人环状结构,含有氮原子.这种化合物具有箱状酸功能组,有助于其酸性.D-Azetidine-2-carboxylic酸因其独特的环状结构而具有结构模拟作用,影响蛋白合成和折叠作用,通常是一种白色至白色晶状固体,可溶于水和极地有机溶剂.这种箱状酸组的存在允许其参与各种化学反应,包括酯化和恐吓.这种化合物对生物化学研究,特别是蛋白结构和功能研究以及药物合成具有兴趣.它是一个D-en-enyomer,它作为D-enyomer,它能影响其生物活动及其与酶和感应体的相互作用.

结构式图片

相似化合物

136552-06-2 2133-34-8 51077-14-6

欧盟法规

C&L通报

上下游产品

CAS号249734-37-0 BENZYL [1(1S),2... | CAS号1758-80-1 L-2,4-二氨基丁酸氢溴酸盐 | CAS号228857-58-7 (R)-N-B°C-氮杂环丁烷-2-羧酸

合成工艺路线路线简述

    📜1-苄氧羰基-氮杂环丁烷-2-甲酸置于palladium On Activated Charcoal 氢气体系中,用 甲醇 作为反应溶剂,化学反应 72.0H,反应生成 D-吖啶-2-羧酸
    参考文献:Identification And Initial Structure−activity Relationships Of (R)-5-(2-Azetidinylmethoxy)-2-Chloropyridine (Abt-594),A Potent,Orally Active,Non-Opiate Analgesic Agent Acting Via Neuronal Nicotinic Acetylcholine Receptors
    标题:Identification And Initial Structure−activity Relationships Of (R)-5-(2-Azetidinylmethoxy)-2-Chloropyridine (Abt-594),A Potent,Orally Active,Non-Opiate Analgesic Agent Acting Via Neuronal Nicotinic Acetylcholine Receptors
    摘要:New Members Of A Previously Reported Series Of 3-Pyridyl Ether Compounds Are Disclosed As Novel,Potent Analgesic Agents Acting Through Neuronal Nicotinic Acetylcholine Receptors. Both (R)-2-Chloro-5-(2-Azetidinylmethoxy)Pyridine (Abt-594,5) And Its S-Enantiomer (4) Show Potent Analgesic Activity In The Mouse Hot-Plate Assay Following Either Intraperitoneal (Ip) Or Oral (Po) Administration,As Well As Activity In The Mouse Abdominal Constriction (Writhing) Assay,A Model Of Persistent Pain. Compared To The S-Enantiomer And To The Prototypical Potent Nicotinic Analgesic Agent (+/-)-Epibatidine,5 Shows Diminished Activity In Models Of Peripheral Side Effects. Structure-Activity Studies Of Analogues Related To 4 And 5 Suggest That The N-Unsubstituted Azetidine Moiety And The 2-Chloro Substituent On The Pyridine Ring Are Important Contributors To Potent Analgesic Activity.
    DOI:10.1021/jm9706224

    海关参考信息

    专利信息


    专利号:US-2023391818-A1
    优先权日:2020-11-05
    标 题:Peptide synthesis method for suppressing defect caused by diketopiperazine formation
    发明人:NOMURA KENICHI; KAGE MIRAI; TAMIYA MINORU; KANAZAWA JUNICHIRO
    权利人:CHUGAI PHARMACEUTICAL CO LTD
    摘要:Solid-phase synthesis of a peptide has a problem that a desired elongation reaction is prevented from proceeding by diketopiperazine and a 6-membered diamine skeleton compound formed when a protective group at the N-terminal is removed. The present inventors have found that when in production of a peptide by a solid-phase method, a peptide in which an amino group at the N-terminal is protected with a protective group having an Fmoc skeleton is treated in a specific solvent with a base having a pKa of 23 or more in acetonitrile as a conjugate acid, and a peptide chain is then elongated, it is possible to solve the problem described above.

    专利号:WO-2023214577-A1
    优先权日:2022-05-02
    标 题 :Peptide synthesis method for suppressing defect caused by diketopiperazine formation
    发明人:KAGE MIRAI; TAMIYA MINORU; KANAZAWA JUNICHIRO; NOMURA KENICHI
    权利人:CHUGAI PHARMACEUTICAL CO LTD
    摘要:The present invention addresses the problem of a desired elongation reaction not progressing as a result of a 6-membered cyclic amidine skeleton structure and a diketopiperazine formed when removing an N-terminated protective group during peptide synthesis. The inventors have discovered that it is possible to solve said problem during peptide production by treating a peptide protected by an N-terminated amino group in a protective group having an Fmoc skeleton by using a base which has a pKa of 23 or higher in an acetonitrile of a conjugate acid in a specific solvent, and next, performing peptide chain elongation.

    专利号:US-7691843-B2
    优先权日:2002-07-11
    标 题 :N-hydroxyamide derivatives possessing antibacterial activity
    发明人:RAJU BORE G; O'DOWD HARDWIN; GAO HONGWU; PATEL DINESH V; TRIAS JAOQUIM
    权利人:PFIZER
    摘要:Novel N-hydroxyamide derivatives are disclosed. These N-hydroxyamide derivatives inhibit UPD-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria and are therefore useful as antimicrobials and antibiotics. Methods of synthesis and of use of the compounds are also disclosed.

    专利号:CN-111334083-B
    优先权日:2018-12-18
    标 题:A Class of Reactive Fluorescent Dyes with High Brightness and High Stability and Their Synthesis and Application

    专利号:CN-111334077-B
    优先权日:2018-12-18
    标题:A kind of high brightness, high stability fluorescent dye excited by 488nm and its synthesis method

    专利号:CN-111333576-B
    优先权日:2018-12-18
    标题 :A class of highly stable wash-free Halo-tag probes and their synthesis and biological applications

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Beck A, Et Al. Strategies And Challenges For The Next Generation Of Antibody-Drug Conjugates. Nat Rev Drug Discov. 2017;16(5):315-337.
    [参考文献]: Nalawansha Da, Et Al. Protacs: An Emerging Therapeutic Modality In Precision Medicine. Cell Chem Biol. 2020;27(8):998-985.

    合成参考文献


    参考文献:10.1007/s00726-022-03136-6
    摘要:Zahradníčková H, Opekar S, Řimnáčová L, Šimek P, Moos M. Chiral secondary amino acids, their importance, and methods of analysis. Amino Acids. 2022 May;54(5):687–719. doi: 10.1007/s00726-022-03136-6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知